Disclosures for "RESET-MG: Clinical Trial Evaluating Rese-cel (Resecabtagene Autoleucel), a Fully Human, Autologous 4-1BB-CD19-CAR T Cell Therapy in Generalized Myasthenia Gravis (gMG)"
-
Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
-
Dr. Ciurea has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CareDx.
-
Dr. Ulane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. The institution of Dr. Ulane has received research support from Cabaletta Bio. The institution of Dr. Ulane has received research support from Arcellx. The institution of Dr. Ulane has received research support from Sanofi.
-
Ran Reshef has nothing to disclose.
-
Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Bioepis. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J. The institution of Dr. Kang has received research support from UCSF resource allocation program .
-
Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BeiGene. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite. The institution of Dr. Seshadri has received research support from Kyverna. The institution of Dr. Seshadri has received research support from Cabaletta Bio. The institution of Dr. Seshadri has received research support from Eli Lilly. The institution of Dr. Seshadri has received research support from Genentech.
-
The institution of Dr. Richman has received research support from Muscular Dystrophy Association.
-
Author has nothing to disclose
-
Mr. Hogan has nothing to disclose.
-
Dr. White has received personal compensation for serving as an employee of Cabaletta Bio.
-
Mrs. Gresh has received personal compensation for serving as an employee of Cabaletta Bio.
-
Mr. HULL has received personal compensation for serving as an employee of Cabaletta Bio.
-
Mr. Furmanak has received personal compensation for serving as an employee of Cabaletta Bio. Mr. Furmanak has stock in Cabaletta Bio.
-
Dr. Volkov has received personal compensation for serving as an employee of Cabaletta Bio.
-
Dr. Nunez has received personal compensation for serving as an employee of CabalettaBio.
-
Mr. Thompson has received personal compensation for serving as an employee of Cabaletta Bio.
-
Dr. Stadanlick has received personal compensation for serving as an employee of Cabaletta Bio. Dr. Stadanlick has stock in Cabaletta Bio.
-
Ms. Ishikawa has received personal compensation for serving as an employee of Cabaletta Bio.
-
Author has nothing to disclose
-
Ms. Ellis has received personal compensation for serving as an employee of Cabaletta Bio. Ms. Ellis has stock in Cabaletta Bio.
-
Mr. Flanagan has received personal compensation for serving as an employee of Cabaletta Bio.
-
Mrs. Werner has received personal compensation for serving as an employee of Cabaletta Bio. Mrs. Werner has stock in cabaletta bio.
-
Mr. Cicarelli has received personal compensation for serving as an employee of Cabaletta Bio.
-
Miss Williams has received personal compensation for serving as an employee of Cabaletta Bio. Miss Williams has stock in Cabaletta Bio.
-
Miss Kobulsky has received personal compensation for serving as an employee of Cabaletta Bio.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Ms. Lam has received personal compensation for serving as an employee of Cabaletta Bio.
-
Dr. Basu has received personal compensation for serving as an employee of Cabaletta Bio. Dr. Basu has stock in Cabaletta Bio. Dr. Basu has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Tummala has received personal compensation for serving as an employee of Cabaletta Bio. Dr. Tummala has stock in Cabaletta Bio.
-
Dr. Chang has received personal compensation for serving as an employee of Cabaletta Bio. Dr. Chang has stock in Cabaletta Bio.